848358-81-6 Usage
Uses
Used in Hair Dye Industry:
2-Amino-4-bromo-5-methylphenol is used as a hair dye ingredient for its ability to impart color to hair. It is valued for its strong coloration properties, which contribute to the effectiveness and long-lasting nature of hair dyes.
Used in Textile Industry:
In the textile industry, 2-amino-4-bromo-5-methylphenol is used as a direct dye for coloring fabrics. Its strong coloration properties allow for vibrant and durable colorfastness in textiles, making it a preferred choice for various types of fabric dyeing processes.
Used in Ink Industry:
2-Amino-4-bromo-5-methylphenol is also utilized in the production of inks due to its strong coloration capabilities. It serves as a pigment in ink formulations, ensuring consistent color output and resistance to fading, which is crucial for high-quality printing applications.
Safety Considerations:
As a hazardous substance, 2-amino-4-bromo-5-methylphenol requires careful handling to prevent skin and eye irritation. It is essential to follow safety guidelines and use appropriate protective equipment when working with this chemical to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 848358-81-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,3,5 and 8 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 848358-81:
(8*8)+(7*4)+(6*8)+(5*3)+(4*5)+(3*8)+(2*8)+(1*1)=216
216 % 10 = 6
So 848358-81-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrNO/c1-4-2-7(10)6(9)3-5(4)8/h2-3,10H,9H2,1H3
848358-81-6Relevant articles and documents
SUBSTITUTED HETEROCYCLIC COMPOUNDS AS CRAC MODULATORS
-
Paragraph 0239, (2016/06/13)
The invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modulation of calcium release-activated calcium (CRAC) channel. The invention also relates to pharmaceutical compositions containing such compounds in treating diseases disorders associated with calcium release-activated calcium (CRAC) channel modulators. wherein, ring D is Formula (a) or Formula (b): A and B, which may be same or different, are independently CR3 or N; Y is CR3 or N; L is selected from —NR2C(O)—, —C(O)NR2— and —NR2CRaRb—; Ra and Rb are independently hydrogen, halogen or substituted or unsubstituted alkyl; ring E is selected from the Formula (i) to (vii).